Kazia Therapeutics KZIA
NASDAQ KZIA
$7.75 -0.32 (-3.97%)
As of: Oct 23, 2026 · 3:08 PM EDT

Kazia Therapeutics (KZIA) Share-based Compensation (IS) (2009 - 2013)

Updated

Kazia Therapeutics (KZIA) reported Share-based Compensation (IS) of -$372,547 for the quarter ended Dec 31, 2013.

Analysis

Kazia Therapeutics (KZIA) Share-based Compensation (IS) (2009 - 2013) Analysis & Trends

For the year ended Dec 31, 2013, Kazia Therapeutics posted Share-based Compensation (IS) of -$389,475.

  • By year, Share-based Compensation (IS) came in at -$513,610 in the year ended Dec 31, 2012, -$502,831 in the year ended Dec 31, 2011, $642,291 in the year ended Jun 30, 2010 and $840,778 in the year ended Dec 31, 2009.
  • The figure for the quarter ended Dec 31, 2013 ranks as the lowest quarterly Share-based Compensation (IS) since the quarter ended Dec 31, 2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,130.05 Bn 1,098.63 Bn 19.71 Bn -
2 Johnson & Johnson 635.34 Bn 555.20 Bn 17.30 Bn -
3 AbbVie 504.85 Bn 477.96 Bn 12.70 Bn -
4 Merck 358.37 Bn 312.75 Bn 12.21 Bn -
5 Novartis Ag 290.48 Bn 254.47 Bn 11.24 Bn -
6 Astrazeneca 265.13 Bn 238.81 Bn 12.86 Bn -
7 Amgen 237.92 Bn 193.32 Bn 7.24 Bn -
8 Gilead Sciences 194.98 Bn 169.17 Bn 6.22 Bn -
9 Pfizer 171.45 Bn 118.10 Bn 10.94 Bn -
10 Kazia Therapeutics 571,281.49 -51.80 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 -372,546.63
Aug 30, 2013 -370,415.50
Dec 31, 2012 -515,189.70
Jun 30, 2010 -643,578.42
Dec 31, 2009 -362,000.00
API Access

Kazia Therapeutics Share-based Compensation (IS) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=KZIA&period=max&api_key=YOUR_API_KEY